To include your compound in the COVID-19 Resource Center, submit it here.

Radius’ rookie win

How Radius got exclusive status for Tymlos with Express Scripts

By coming in with a low list price designed to reduce out-of-pocket costs for Medicare patients, Radius Health Inc. also managed the rare feat of getting exclusive placement on Express Scripts Holding Co.’s formulary just months into the launch of Tymlos abaloparatide-SC.

Express Scripts uses excluded drugs lists and exclusive formulary status to manage costs in therapeutic categories where more than one drug is approved.

The PBM’s P&T committee first determines which drugs in a given category are clinically equivalent. Those drugs

Read the full 802 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers